Genmab | GEN - 当期純利益





当期純利益 変化する 日付
Agios Pharmaceuticals USD -100.7M 1.59M 2026-06
Almirall EUR 24.25M 4.68M 2026-06
Amarin USD -1.22M 6.51M 2025-12
Amgen USD 3.86B 1.49B 2026-09
argenx SE USD 506M 34M 2026-09
AstraZeneca USD 3.12B 610M 2026-09
Bayer EUR -672M 891M 2026-09
BioMarin Pharmaceutical USD -122.83M 167.59M 2026-09
Demant DKK 1.18B 758M 2026-06
Exelixis USD 218.1M 6.04M 2026-09
Fresenius Medical Care EUR 160M 58.38M 2026-09
Genmab DKK 303M 250M 2026-06
GlaxoSmithKline GBP 1.54B 1.11B 2026-09
GN Store Nord DKK 356M 378M 2026-09
GRIFOLS EUR 162M 8M 2026-09
Hikma Pharmaceutical USD 164M 45M 2025-12
Insmed USD -13.24M 150.32M 2026-06
Lakefront Biotherapeutics EUR 2.11M 12.38M 2026-06
Lonza CHF 426M 119M 2025-06
Merck EUR 490M 169M 2026-06
Novartis USD 1.2B 2.06B 2026-09
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sanofi EUR 3.02B 2.68B 2026-09
UCB EUR 1.08B 608M 2025-12